Madrigal Pharmaceuticals (LTS:0JXI) Accounts Payable & Accrued Expense : $147.9 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Madrigal Pharmaceuticals Accounts Payable & Accrued Expense?

Madrigal Pharmaceuticals's quarterly accounts payable & accrued expense declined from Sep. 2024 ($147.3 Mil) to Dec. 2024 ($133.3 Mil) but then increased from Dec. 2024 ($133.3 Mil) to Mar. 2025 ($147.9 Mil).

Madrigal Pharmaceuticals's annual accounts payable & accrued expense increased from Dec. 2022 ($100.4 Mil) to Dec. 2023 ($101.0 Mil) and increased from Dec. 2023 ($101.0 Mil) to Dec. 2024 ($133.3 Mil).

Madrigal Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Madrigal Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Madrigal Pharmaceuticals Accounts Payable & Accrued Expense Chart

Madrigal Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

41.55

69.66

100.43

100.99

133.34

Madrigal Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															96.85	103.26	147.29	133.34	147.95

Madrigal Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Madrigal Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Madrigal Pharmaceuticals Inc (LTS:0JXI) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

MDGL:USA YDO1:Germany

Address

200 Barr Harbor Drive, Suite 200, Four Tower Bridge, West Conshohocken, PA, USA, 19428

Website

https://www.madrigalpharma.com

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Madrigal Pharmaceuticals Headlines

No Headlines